Health Care: Drugs

Navidea Biopharmaceuticals Inc (NAVB: OTC)

$0.475 n/a | n/a%
07/21/17 - 04:02 PM ET
Company Profile
Price and Volume
Recent Price 0.48
52 Week High 1.16
52 Week Low 0.26
Avg. Daily Vol. (Mil) 0.38
Beta (3 year) -0.94
Share Related Items
Mkt Cap (Mil) 77.71
Shares Out (Mil) 161.90
Float (Mil) 155.38
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.10
Current Ratio 2.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.10
Valuation Ratios
Price Earnings 1.00
Price/Sales 4.31
Price/Book 3.54
Price/Cash Flow 1.00
Per Share Data
Earnings 0.46
Sales 0.11
Book Value 0.13
Cash Flow 0.47
Business Summary
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.
General Information
5600 Blazer Parkway
Suite 200
Dublin, OH 43017-7550
www.navidea.com
Industry : Drugs
Sector: Health Care
Employees: 22
CEO: Dr. Michael M. Goldberg,M.D.
Short Interest
Current Month (Mil) 12.48
Previous Month (Mil) 12.74
Short Interest Ratio (Days) 30.50
Management Effectiveness
Return on Equity 345.50
Return on Assets 227.70
Return on Investments 345.50
Profitability
Gross Margin 92.60
EBIT Margin -12.80
Profit Margin 0.00

Portfolios with NAVB

Latest NAVB Headlines from TheStreet

More Financial News for NAVB

Press Releases for NAVB

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter